Psyence BioMed (@PsyenceBiomed) header
Psyence BioMed (@PsyenceBiomed) profile picture

A life sciences biotechnology company focused on developing nature-derived psilocybin and ibogaine-based psychedelic medicines. $PBM

Joined March 2025
Photo by Psyence BioMed (@PsyenceBiomed)Photo by Psyence BioMed (@PsyenceBiomed)Photo by Psyence BioMed (@PsyenceBiomed)Photo by Psyence BioMed (@PsyenceBiomed)Photo by Psyence BioMed (@PsyenceBiomed)Photo by Psyence BioMed (@PsyenceBiomed)Photo by Psyence BioMed (@PsyenceBiomed)Photo by Psyence BioMed (@PsyenceBiomed)Photo by Psyence BioMed (@PsyenceBiomed)Photo by Psyence BioMed (@PsyenceBiomed)
Our engagement across Texas continues. As states explore evidence-based approaches to ibogaine research and future therapeutic access, we remain committed to being part of the conversation. #Ibogaine #MentalHealth #Biotechnology #ClinicalResearch #Psychedelics #Texas
1
1
2
1,462
We're excited to be recognized by CNBC as one of the companies helping advance the next generation of ibogaine-based therapies. "Several biotechs are studying ibogaine and derivatives, including AtaiBeckley, Gilgamesh, Psyence BioMed and DemeRx." cnbc.com/amp/2026/07/19/psyc… $PBM
2
5
2,009
POLITICO quotes Psyence CEO Jody Aufrichtig on ethical ibogaine. "Our goal is to lay the foundations for the use of ibogaine worldwide." politico.com/newsletters/pre… #psychedelics #ibogaine #mentalhealth #Veterans $PBM
4
105
We’re pleased to announce that PsyLabs is a Gold Sponsor of #ICPR2026 taking place June 4–6 in The Netherlands. Attending from our team: Jody Aufrichtig (Psyence BioMed), Tony Budden, Dr. John Thorne, and Cody Futeran. #Psychedelics #MentalHealth #Biotech #PsychedelicResearch
1
4
106
Interesting opinion piece from Amber and Marcus Capone on the growing conversation around psychedelic-assisted therapies for veterans and the need to continue advancing research in this space. bostonglobe.com/2026/05/25/o… #psychedelics #mentalhealth #ibogaine $PBM
1
49
Proud to see Psyence BioMed featured on the @Nasdaq @NasdaqExchange Tower in Times Square as we continue advancing regulated clinical ibogaine research and GMP manufacturing infrastructure globally. $PBM #Nasdaq #Ibogaine #Psychedelics #Biotech #MentalHealth #ClinicalResearch
2
1
7
224
Psyence BioMed CEO Letter Highlights Clinical Progress, Ethical sourcing of Ibogaine, Strong Cash Position and Expanding Leadership in Longevity Science. Full press release and letter ⬇️ psyencebiomed.com/psyence-bi… #psychedelics #psilocybin #ibogaine #Nasdaq #longevity $PBM
4
2
163
We appreciate @LongevityTech highlighting Psyence BioMed’s leadership in advancing psychedelic science and human longevity. Full story here: longevity.technology/news/ps… #longevityscience #psychedelics #psilocybin #innovation #nasdaq $PBM
1
2
139
$PBM CEO Jody Aufrichtig shares his vision for the future of longevity science and psychedelics - not to live forever, but to live better. Read the full op-ed here: psyencebiomed.com/opinion-th… #psychedelics #longevityscience #aging #antiaging #psilocybin #media
1
1
1
183
Today, we’re proud to share we have launched the first-ever psilocybin longevity research initiative by a publicly listed company. Read the full announcement here: psyencebiomed.com/announces-… #psychedelics #agingscience #psilocybin #longevity #biology $PBM
1
100
PRESS RELEASE: Psyence BioMed Announces USD$500,000 Follow-On Investment in PsyLabs and Global Ibogaine Supply. Agreementhttps://psyencebiomed.com/investment-in-psylabs-and-global-ibogaine-supply-agreement/ $PBM #psychedelics #Ibogaine #psilocybin #biopharma #Nasdaq #PsyLabs
2
3
325
Reminder: Psyence BioMed Corporate Webinar today at 12:00PM EST. Access the Zoom link below 👇 us06web.zoom.us/j/8970091088… #psychedelics #psilocybin #stocks #StocksToWatch #investors #biopharma $PBM
1
149
Please join us on Thursday, April 10th @ 12:00PM EST for our first corporate webinar with $PBM CEO, Dr. Neil Maresky, CMO, Dr. Clive Ward-Able, and CFO, Warwick Corden Lloyd. See you there! #psychedelics #psilocybin #Nasdaq #biopharma Register here ⤵️ psyencebiomed.com/corporate-…
75